The global market for Interventional Radiology Systems was valued at US$27.0 Billion in 2024 and is projected to reach US$40.6 Billion by 2030, growing at a CAGR of 7.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The adoption of interventional radiology systems has transformed the landscape of medical treatment by providing less invasive options for patients. The use of real-time imaging allows for precise navigation of instruments within the body, enhancing the accuracy and effectiveness of treatments. This has led to improved patient outcomes, shorter hospital stays, and reduced healthcare costs. The versatility of IR systems makes them applicable in various medical fields, including oncology, cardiology, neurology, and gastroenterology. The continuous advancements in imaging technology and the integration of digital health solutions are further enhancing the capabilities of interventional radiology.
The growth in the interventional radiology systems market is driven by several factors. The increasing prevalence of chronic diseases such as cardiovascular disorders and cancer is a significant driver, as minimally invasive treatments become a preferred option. Technological advancements in imaging and navigation systems are enabling more precise and effective procedures. The rising demand for minimally invasive surgeries, which offer reduced recovery times and lower risk of complications, is also contributing to market growth. Additionally, the growing aging population and the associated increase in age-related conditions are fueling the demand for interventional radiology. The integration of AI and machine learning in imaging systems is enhancing diagnostic accuracy and procedural outcomes, further driving the adoption of these advanced systems.
Global Interventional Radiology Systems Market - Key Trends & Drivers Summarized
Interventional radiology (IR) systems are specialized medical imaging equipment used to perform minimally invasive procedures guided by real-time imaging. These systems include a range of tools such as fluoroscopy, ultrasound, CT, and MRI among others, which allow physicians to diagnose and treat various conditions with precision. Interventional radiology offers an alternative to traditional surgery by enabling targeted treatments through small incisions, reducing recovery times and minimizing complications. Common procedures performed using IR systems include angioplasty, stent placement, embolization, and biopsies, which are used to treat conditions such as cardiovascular diseases, cancer, and neurological disorders.The adoption of interventional radiology systems has transformed the landscape of medical treatment by providing less invasive options for patients. The use of real-time imaging allows for precise navigation of instruments within the body, enhancing the accuracy and effectiveness of treatments. This has led to improved patient outcomes, shorter hospital stays, and reduced healthcare costs. The versatility of IR systems makes them applicable in various medical fields, including oncology, cardiology, neurology, and gastroenterology. The continuous advancements in imaging technology and the integration of digital health solutions are further enhancing the capabilities of interventional radiology.
The growth in the interventional radiology systems market is driven by several factors. The increasing prevalence of chronic diseases such as cardiovascular disorders and cancer is a significant driver, as minimally invasive treatments become a preferred option. Technological advancements in imaging and navigation systems are enabling more precise and effective procedures. The rising demand for minimally invasive surgeries, which offer reduced recovery times and lower risk of complications, is also contributing to market growth. Additionally, the growing aging population and the associated increase in age-related conditions are fueling the demand for interventional radiology. The integration of AI and machine learning in imaging systems is enhancing diagnostic accuracy and procedural outcomes, further driving the adoption of these advanced systems.
Scope of the Study
The report analyzes the Interventional Radiology Systems market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments:
Product (MRI Systems, Ultrasound Imaging Systems, CT Scanners, Angiography Systems, Fluoroscopy Systems, Biopsy Systems, Other Products); Application (Cardiology, Oncology, Urology & Nephrology, Gastroenterology, Other Applications).Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the MRI Systems segment, which is expected to reach US$12.7 Billion by 2030 with a CAGR of a 8.1%. The Ultrasound Imaging Systems segment is also set to grow at 7.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $8.1 Billion in 2024, and China, forecasted to grow at an impressive 9.3% CAGR to reach $4.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Barco NV and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Interventional Radiology Systems Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Interventional Radiology Systems Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Interventional Radiology Systems Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 92 major companies featured in this Interventional Radiology Systems market report include:
- Abbott Laboratories, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Barco NV
- Agfa-Gevaert NV
- Analogic Corporation
- AngioDynamics, Inc.
- Biosensors International Group Ltd.
- Allengers Medical Systems Ltd.
- Aurora Imaging Technology, Inc.
- Animage, LLC
- Beijing Wandong Medical Technology Co., Ltd.
- Arrays Medical Imaging Corporation
- Amolab srl
Table of Contents
I. METHODOLOGYMII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAFRANCEITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories, Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Barco NV
- Agfa-Gevaert NV
- Analogic Corporation
- AngioDynamics, Inc.
- Biosensors International Group Ltd.
- Allengers Medical Systems Ltd.
- Aurora Imaging Technology, Inc.
- Animage, LLC
- Beijing Wandong Medical Technology Co., Ltd.
- Arrays Medical Imaging Corporation
- Amolab srl
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 500 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 27 Billion |
| Forecasted Market Value ( USD | $ 40.6 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
